These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

675 related items for PubMed ID: 19604721

  • 41. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH.
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [Abstract] [Full Text] [Related]

  • 42. Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria.
    Rendi-Wagner P, Georgopoulos A, Kundi M, Mutz I, Mattauch M, Nowak J, Mikolasek A, Vecsei A, Kollaritsch H.
    J Antimicrob Chemother; 2004 May; 53(5):826-31. PubMed ID: 15073163
    [Abstract] [Full Text] [Related]

  • 43. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R.
    Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
    [Abstract] [Full Text] [Related]

  • 44. Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections.
    Horácio AN, Diamantino-Miranda J, Aguiar SI, Ramirez M, Melo-Cristino J, Portuguese Group for Study of Streptococcal Infections.
    Vaccine; 2012 Jan 05; 30(2):218-24. PubMed ID: 22100892
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
    Muñoz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, Sauca G, Gallés C, Morta M, Ballester F, Raga X, Selva L, Catalan study group of invasive pneumococcal disease.
    J Infect; 2011 Aug 05; 63(2):151-62. PubMed ID: 21679725
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991-1998.
    Rudolph KM, Parkinson AJ, Reasonover AL, Bulkow LR, Parks DJ, Butler JC.
    J Infect Dis; 2000 Aug 05; 182(2):490-6. PubMed ID: 10915080
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential.
    Hsieh YC, Lin PY, Chiu CH, Huang YC, Chang KY, Liao CH, Chiu NC, Chuang YC, Chen PY, Chang SC, Liu JW, Yen MY, Wang JH, Liu CY, Lin TY.
    Vaccine; 2009 Sep 04; 27(40):5513-8. PubMed ID: 19615960
    [Abstract] [Full Text] [Related]

  • 55. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998-2003.
    Wasfy MO, Pimentel G, Abdel-Maksoud M, Russell KL, Barrozo CP, Klena JD, Earhart K, Hajjeh R.
    J Antimicrob Chemother; 2005 Jun 04; 55(6):958-64. PubMed ID: 15820983
    [Abstract] [Full Text] [Related]

  • 56. Active surveillance of Streptococcus pneumoniae bacteremia in Italian children.
    Tarallo L, Tancredi F, Schito G, Marchese A, Bella A, Italian Pneumonet Group (Società Italiana Pediatria and Associazione Italiana Studio Antimicrobici e Resistenze).
    Vaccine; 2006 Nov 17; 24(47-48):6938-43. PubMed ID: 16901591
    [Abstract] [Full Text] [Related]

  • 57. Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique.
    Vallès X, Flannery B, Roca A, Mandomando I, Sigaúque B, Sanz S, Schuchat A, Levine M, Soriano-Gabarró M, Alonso P.
    Trop Med Int Health; 2006 Mar 17; 11(3):358-66. PubMed ID: 16553916
    [Abstract] [Full Text] [Related]

  • 58. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
    Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A, Active Bacterial Core Surveillance of the Emerging Infections Program Network.
    N Engl J Med; 2003 May 01; 348(18):1737-46. PubMed ID: 12724479
    [Abstract] [Full Text] [Related]

  • 59. Pneumococcal serotype distribution and antimicrobial resistance in Chinese children hospitalized for pneumonia.
    Yao KH, Wang LB, Zhao GM, Zheng YJ, Deng L, Huang JF, Wang JX, Zhao RZ, Deng QL, Hu YH, Yu SJ, Yang YH, Young M.
    Vaccine; 2011 Mar 09; 29(12):2296-301. PubMed ID: 21276441
    [Abstract] [Full Text] [Related]

  • 60. Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany.
    Imöhl M, Reinert RR, van der Linden M.
    Int J Med Microbiol; 2015 Oct 09; 305(7):776-83. PubMed ID: 26324014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.